Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06298591
Other study ID # atrophic scar treatment
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 15, 2024
Est. completion date March 15, 2027

Study information

Verified date March 2024
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

There are more than 100 million patients who develop scar formation caused by various factors, such as post-inflammatory acne and trauma (1). They often have physical, aesthetic, psychological, and social barriers. Scar tissue is naturally a stage of wound healing. Abnormal wound healing produces a spectrum of scar tissue types such as atrophic, hypertrophic, and keloid scars (2). Atrophic scars are dermal depressions, which are commonly caused by the destruction of collagen following inflammatory process. This permanent disfiguring sequelae correlates with the duration of pathology, severity of lesion, and delay in therapy (3). Treatment of atrophic acne scars remains a therapeutic challenge, yet there is no standard option as the most effective treatment (4). A range of possible options has been investigated including surgical techniques (subcision, non-ablative laser treatment, resurfacing techniques (ablative laser treatment, dermabrasion), and injection or dermal fillers or fat, and a combination of two or more modalities (5). Ultrasound is a unique non-invasive and non-radiating medical imaging tool in the investigation of dermatological diseases by providing detailed anatomic and physiologic data of skin lesions and deeper soft tissue changes. Lesion size in three dimensions-lengths, width, and depth, morphology, the detailed anatomic information provided by sonography is useful to assessment of effect of different types of treatment modality to improve atrophic scar and avoid invasive assessment tools as punch biopsy for histopathological examination (6)


Description:

atrophic scar mangment


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 45
Est. completion date March 15, 2027
Est. primary completion date March 15, 2027
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 12 Years to 70 Years
Eligibility Inclusion Criteria: - Patients aged from 12 to 60 years with - post inflammatory atrophic scar. - post traumatic atrophic scar. - post operative atrophic scar Exclusion Criteria: - post acne scar. - active skin infection.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
co2 laser
laser

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Outcome

Type Measure Description Time frame Safety issue
Primary change of dermal thickness in sonar and Vancouver scale objective 3 years
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06435884 - Long-Term Follow-up of Adult With Atorpphic Scars Treated With TRTP-101
Completed NCT06000839 - A Safety and Effectiveness Study of CELLBOOSTER® Lift (Stabilized Booster Complex Using CHAC Technology) N/A
Recruiting NCT05936437 - Clinical Benefits and Safety of Combined Polynucleotides and Hyaluronic Acid - Newest - for Acne Scars Treatment N/A
Active, not recruiting NCT04519515 - Vollure for the Correction of Atrophic Facial Scarring N/A
Completed NCT03264573 - Role of Stem Cells, Platelet Rich Plasma in Treatment of Scars N/A
Not yet recruiting NCT05695807 - Carboxytherapy in the Treatment of Atrophic Scars N/A
Recruiting NCT06210919 - Safety and Tolerability of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars Phase 1
Completed NCT05686603 - Comparison of Picosecond Lasers vs. Ablative Fractional Er:YAG Lasers in Treating Atrophic Scar N/A